Variable (n=10)                                                              median ± SD Age (years) 51.00 ± 6.36 (38.00-56.00) Men, n (%) 8/10 (80%) Women, n (%) 2/10 (20%) Weight (kg) 68.07 ± 18.29 (51.07-111.23) Height (cm) 171.00 ± 7.28 (151.00-185.00) Time of HIV infection (years) 15.50 ± 4.61 (5.00-17.00) Use of HAART (years) 13.50 ± 5.17 (2.00-17.00) CD4+ cells (cells/μL) Viral load (copies/μL) Use of PI, n (%) Use of de RTNI, n (%) Use of RTNNI, n (%) 479.50 ± 269.43 (160.00-867.00) 69.00 ± 41.55 (<50.00-110.00) 8 (80%) 9 (90%) 7 (70%) PI – Protease inhibitors RTNI – Reverse transcriptase nucleoside inhibitors RTNNI – Reverse transcriptase non-nucleoside inhibitors

Table 1: Characterization of the patients included in the study according to age, body weight, height, time of HIV infection, time of use of highly active antiretroviral therapy (HAART), number of T-CD4+ cells, viral burden and medication class at the time of the study.

Goto home»